Michele Carbone

20.9k citations

208 papers · 13.1k indexed · 3 hit papers · h-index 63

Impact in

Pulmonary and Respiratory Medicine top 0.1%
- Occupational and environmental lung diseases
- Pleural and Pulmonary Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Medical Imaging and Pathology Studies
Biotechnology top 0.2%
- Cancer Research and Treatments

Papers in

Pulmonary and Respiratory Medicine 152
- Occupational and environmental lung diseases 138
- Medical Imaging and Pathology Studies 52
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 37
- Pleural and Pulmonary Diseases 27
Biotechnology 22
- Cancer Research and Treatments 22

Co-authors: Harvey I. Pass Haining Yang Joseph R. Testa Giovanni Gaudino Paola Rizzo Amy Powers Maurizio Bocchetta Adi F. Gazdar
Journals: Cancer Research (14 papers)Journal of Thoracic Oncology (12 papers)Oncogene (10 papers)Proceedings of the National Academy of Sciences (9 papers)Clinical Cancer Research (5 papers)
Partner nations: United States Italy Canada

In The Last Decade

Michele Carbone

203 papers receiving 12.8k citations

Hit Papers

align trajectories log scale

BAP1 and cancer 2013 · 462 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Nature reviews. Cancer
2011 Nature Genetics
2008 Journal of Thoracic and Cardiovascular Surgery

Peers

Countries citing papers authored by Michele Carbone

Since Specialization

Citations

This map shows the geographic impact of Michele Carbone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Carbone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Carbone more than expected).

Fields of papers citing papers by Michele Carbone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Carbone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Carbone. The network helps show where Michele Carbone may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michele Carbone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michele Carbone Line = papers co-authored together Michele Carbone links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	When vaccines reset tumors: SARS-CoV-2 mRNA shots create a transient checkpoint-sensitive state Signal Transduction and Targeted Therapy ·Naglaa Shahin, Michele Carbone, 杨艳萍	2025	0
2	Mineralogical investigation of asbestos contamination of soil near old vermiculite processing plant in Honolulu, Hawaiʻi Environmental Pollution ·Μαρία Μπουτζέτη, Michele Carbone, 徐勤琪, I V Golubev, Ronald F. Dodson, Przemysław Dera	2024	2
3	Molecular Mechanisms of Autophagy in Cancer Development, Progression, and Therapy Biomedicines ·Veronica Angela Maria Vitto, Young-Wha Kim, 杜静仪, Izquierdo Encarnación N, Alessandro Rimessi, Xinye Jiang, Haining Yang, Michele Carbone, Paolo Pinton, Carlotta Giorgi, Simone Patergnani	2022	32
4	Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy Proceedings of the National Academy of Sciences ·Jiaming Xue, Simone Patergnani, Carlotta Giorgi, Joelle Sacks Suarez, Keisuke Goto, Angela Bononi, Mika Tanji, Flavia Novelli, Sandra Pastorino, Ronghui Xu, Natascia Caroccia, A. Umran Doğan, Harvey I. Pass, Mauro Tognon, Paolo Pinton, Giovanni Gaudino, Tak W. Mak, Michele Carbone, Haining Yang	2020	57
5	Scientific Advances and New Frontiers in Mesothelioma Therapeutics Journal of Thoracic Oncology ·Luciano Mutti, Tobias Peikert, B. W. Robinson, Arnaud Scherpereel, Anne S. Tsao, Marc de Perrot, Gavitt A. Woodard, David M. Jablons, Jacinta Wiens, Fred R. Hirsch, Haining Yang, Michele Carbone, Anish Thomas, Raffit Hassan	2018	69
6	HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients Clinical Cancer Research ·Andrea Napolitano, Daniel J. Antoine, Laura Pellegrini, Francine Baumann, Ian Pagano, Sandra Pastorino, Chandra Goparaju, 昌津田, Claudia Canino, Harvey I. Pass, Michele Carbone, Haining Yang	2016	83
7	Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies Expert Review of Respiratory Medicine ·Angela Bononi, Andrea Napolitano, Harvey I. Pass, Haining Yang, Michele Carbone	2015	37
8	High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma Journal of Thoracic Oncology ·Masaki Nasu, Mitsuru Emi, Sandra Pastorino, Mika Tanji, Amy Powers, Hugh Luk, Francine Baumann, Yu‐An Zhang, Adi F. Gazdar, Shreya Kanodia, Maarit Tiirikainen, Erin Flores, Giovanni Gaudino, Michael J. Becich, Harvey I. Pass, Haining Yang, Michele Carbone	2015	216
9	Whole-Exome Sequencing Reveals Frequent Genetic Alterations in BAP1 , NF2 , CDKN2A , and CUL1 in Malignant Pleural Mesothelioma Cancer Research ·Guangwu Guo, Juliann Chmielecki, Chandra Goparaju, Adriana Heguy, Igor Dolgalev, Michele Carbone, Sara Seepo, Matthew Meyerson, Harvey I. Pass	2014	229
10	Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma Cancer Research ·Sandro Jube, Zeyana S. Rivera, Marco E. Bianchi, Amy Powers, Ena Wang, Ian Pagano, Harvey I. Pass, Giovanni Gaudino, Michele Carbone, Haining Yang	2012	199
11	CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma Clinical Cancer Research ·Zeyana Rivera, Soldano Ferrone, Xinhui Wang, Sandro Jube, Haining Yang, Harvey I. Pass, Shreya Kanodia, Giovanni Gaudino, Michele Carbone	2012	76
12	hsa-miR-29c* Is Linked to the Prognosis of Malignant Pleural Mesothelioma Cancer Research ·Harvey I. Pass, Chandra Goparaju, Sergey V. Ivanov, Jessica Donington, Michele Carbone, Moshe Hoshen, Dalia Cohen, Ayelet Chajut, Shai Rosenwald, Wyatt Egelhoff, Sima Benjamin, Ranit Aharonov	2010	107
13	A Novel Mechanism of Late Gene Silencing Drives SV40 Transformation of Human Mesothelial Cells Cancer Research ·Michele Carbone, Antonio Pannuti, Lei Zhang, Joseph R. Testa, Maurizio Bocchetta	2008	24
14	The SV40 Large T Antigen-p53 Complexes Bind and Activate the Insulin-like Growth Factor-I Promoter Stimulating Cell Growth Cancer Research ·Maurizio Bocchetta, A. Sathish Reddy, Melissa A. De Marco, County Stakeholders, Lei Zhang, Michele Carbone	2008	68
15	Role of Ubiquitin-proteasome proteolytic pathway in malignant pleural mesothelioma. Cancer Research ·Anil Wali, Ying Wang, 宮村和寿, Zhandong Liu, Sunita Sharma, Fulvio Lonardo, Arun K. Rishi, Adhip P.N. Majumdar, Q. Ping Dou, Michele Carbone, John C. Ruckdeschel, Harvey I. Pass	2007	1
16	PICOT gene expression levels can predict survival and recurrence among malignant pleural mesothelioma patients Cancer Research ·Anil Wali, Patrice J. Morin, Colleen D. Hough, Fulvio Lonardo, 宮村和寿, Zhandong Liu, Maria Lynn B. Carbonell, Sorin Drăghici, Michele Carbone, ศรีลาวัลย์ สัจจะสกุลชัย, Harvey I. Pass	2005	1
17	High throughput testing of the SV40 Large T antigen binding to cellular p53 identifies putative drugs for the treatment of SV40-related cancers Virology ·Michele Carbone, County Stakeholders, Maurizio Bocchetta	2003	11
18	No Evidence of HIV and SIV Sequences in Two Separate Lots of Polio Vaccines Used in the First U.S. Polio Vaccine Campaign Virology ·Paola Rizzo, Mo Hadi, Amy Powers, Amaal Shehata, Jonathan L. Heeney, Vacuro Eg, Michele Carbone	2001	2
19	Simian virus-40 large-t antigen binds p53 in human mesotheliomas Pneumologie ·Michele Carbone, Paola Rizzo, Philip M. Grimley, Antonio Domenico Procopio, Daphne Mew, Vijayalakshmi Shridhar, Andrea de Bartolomeis, Mestrando em Administração, Mariateresa Giuliano, S. M. Steinberg, Indriani Umar, Antonio Giordano	1998	2
20	The biological activities of simian virus 40 large-T antigen and its possible oncogenic effects in humans. PubMed ·Julie Le Faouder, Paola Rizzo, Harvey I. Pass, V.M. Novoselov, Ann M. Powers, Luciano Mutti, W. Martin Kast, Michele Carbone	1998	5

About Michele Carbone

Michele Carbone is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology, Oncology, Clinical Biochemistry and Cancer Research, having authored 208 papers that have together received 13.1k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (138 papers), Medical Imaging and Pathology Studies (52 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (37 papers), Polyomavirus and related diseases (27 papers), Pleural and Pulmonary Diseases (27 papers), Cancer Research and Treatments (22 papers), Virus-based gene therapy research (16 papers) and Cancer-related Molecular Pathways (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (8.0k citations), Biotechnology (1.1k citations), Oncology (3.3k citations), Cancer Research (1.2k citations) and Immunology (1.2k citations). Michele Carbone has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Harvey I. Pass, Haining Yang, Joseph R. Testa, Giovanni Gaudino, Paola Rizzo, Amy Powers, Maurizio Bocchetta, Adi F. Gazdar, Francine Baumann and Thomas Krausz. Their work appears in journals such as Cancer Research, Journal of Thoracic Oncology, Oncogene, Proceedings of the National Academy of Sciences and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact